New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Oncology January 23,2024
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Oncology January 23,2024
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Oncology January 23,2024
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Oncology January 23,2024
Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas
Oncology January 23,2024
Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas
Oncology January 23,2024
Cell fate choice during adult regeneration is highly disorganized, study finds

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,
Oncology January 23,2024
Cell fate choice during adult regeneration is highly disorganized, study finds

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,
Oncology January 23,2024
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be
Oncology January 23,2024
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be
Oncology January 23,2024
Survival of children with acute lymphatic leukemia has increased to 94%, study finds

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e
Oncology January 23,2024
Survival of children with acute lymphatic leukemia has increased to 94%, study finds

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e
Oncology January 23,2024
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more
Oncology January 23,2024
Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more
Oncology January 23,2024
Study identifies enzyme that helps tumors evade the immune system

Study identifies enzyme that helps tumors evade the immune system

by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
Oncology January 23,2024
Study identifies enzyme that helps tumors evade the immune system

Study identifies enzyme that helps tumors evade the immune system

by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
Oncology January 23,2024
Study finds that brain tumors 'hack' the communication between neurons

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur
Oncology January 23,2024
Study finds that brain tumors 'hack' the communication between neurons

Study finds that brain tumors 'hack' the communication between neurons

byThe Spanish National Cancer Research CentreThe metastasis (lighter green) is shown to interact with a neuron (brighter green). This neuron has been artificially marked for research, but is sur
Oncology January 23,2024
Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s
Oncology January 23,2024
Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

Each year spent working with certain chemicals raises risk of pancreatic cancer, finds study

by Dennis ThompsonJobs that regularly expose you to certain chemicals appear to steadily increase your risk of pancreatic cancer, a new analysis reports.People with more than 20 years of exposure to s
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com